公开(公告)号：US11160925B1

公开(公告)日：2021-11-02

申请号：US17179984

申请日：2021-02-19

Applicant: Insulet Corporation

Inventor： Trang Ly ,  Matt Rainville ,  M. Thomas Andersen

IPC: A61M5/172 ,  A61M5/142 ,  A61M5/14 ,  A61K38/28 ,  A61K38/26

Abstract: The disclosed embodiments are directed to a wearable automatic drug delivery device configured to provide basal dosing of GLP-1 or co-formulation of GLP-1 and insulin. The size and frequency of the basal doses may be controlled by a medication delivery algorithm resident on the wearable drug delivery device based on a basal dosing history and readings from a continuous glucose monitor monitoring the glucose levels of the wearer of the device.